Atlas Trials

Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders

Clinical trial NCT02476409 · COMPLETED

Trial details

NCT number
NCT02476409
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Congestive Heart Failure
Start date
2015-07-01
Primary completion
2021-05-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.